2nd Protein Degradation for CNS Summit | Brand-New Program
Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to undruggable CNS target
Newsletters and Deep Dive digital magazine
Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to undruggable CNS target
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depre
Lexeo Therapeutics' gene therapy for Alzheimer's has shown that it can reduce biomarkers of the disease in a small study, including reductions in disease biomarkers.
Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.
Editor's Picks
Newsletters and Deep Dive
digital magazine